Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-10-03 | 2020-03-26 | 95411 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-10-20 | 2024-02-14 | 172263 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-08-18 | 2022-09-08 | 167159 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-10-03 | 2020-04-02 | 95408 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-09-22 | 2024-02-14 | 169966 |
| NOVAMOXIN | 500MG | CAPSULE | Resolved | 2025-11-27 | 2025-12-13 | 272751 |
| NOVAMOXIN | 500MG | CAPSULE | Resolved | 2020-03-12 | 2020-03-26 | 108610 |
| NOVAMOXIN | 500MG | CAPSULE | Resolved | 2022-12-01 | 2023-07-05 | 176767 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-05-14 | 2020-06-04 | 115196 |
| NOVAMOXIN | 500MG | CAPSULE | Resolved | 2025-05-15 | 2025-07-03 | 257521 |
| NOVAMOXIN | 250MG | TABLET (CHEWABLE) | Resolved | 2025-05-22 | 2025-07-18 | 258118 |
| NOVAMOXIN | 500MG | CAPSULE | Resolved | 2020-04-16 | 2020-05-08 | 112364 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-04-10 | 2020-04-23 | 111841 |
| NOVAMOXIN | 250MG | TABLET (CHEWABLE) | Resolved | 2020-03-26 | 2020-07-09 | 109604 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-04-03 | 2017-05-23 | 5165 |
| NOVO-CYPROTERONE/ETHINYL ESTRADIOL | 0.035MG 2MG | TABLET | Resolved | 2017-04-25 | 2017-09-19 | 8068 |
| NOVO-GESIC | 325MG | TABLET | Resolved | 2019-06-27 | 2020-03-19 | 87680 |
| NOVO-GESIC | 325MG | TABLET | Resolved | 2022-08-18 | 2022-09-23 | 167229 |
| NOVO-GESIC | 325MG | TABLET | Resolved | 2020-03-26 | 2020-05-21 | 109571 |
| NOVO-GESIC FORTE | 500MG | TABLET | Resolved | 2020-04-10 | 2020-06-04 | 111829 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NAPROXEN SODIUM | 275MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258522 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
| TEVA-OLMESARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258409 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258412 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258405 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258400 |
| TEVA-OLMESARTAN / HCTZ | 25MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258396 |
| TEVA-ONDANSETRON | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258774 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258729 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
| TEVA-PAROXETINE | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258433 |
| TEVA-PAROXETINE | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258430 |